Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Inpatient Management of Type 2 Diabetes
NCT02455076Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2015
- Primary completion
- Mar 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Emory University. Started Sep 2015; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02455076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02455076.